Crescita Therapeutics Inc (CTX.TO) revealed Loss for third quarter that decreased from last year
The company's bottom line totaled -C$1.036 billion, or -C$0.05 per share. This compares with -C$1.282 billion, or -C$0.06 per share, in last year's third quarter.
The company's revenue for the quarter rose 18.5% to C$3.594 million from C$3.033 million last year.
Crescita Therapeutics Inc earnings at a glance (GAAP) :
-Earnings (Q3): -C$1.036 Bln. vs. -C$1.282 Bln. last year.-EPS (Q3): -C$0.05 vs. -C$0.06 last year.-Revenue (Q3): C$3.594 Mln vs. C$3.033 Mln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.